Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention. [PDF]
Front Med (Lausanne)Rottura M +12 more
europepmc +1 more source
PCSK9 - A New and Potent Approach to Lowering Cholesterol [PDF]
, 2013 Thomas F. Whayne
openalex +1 more source
The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus. [PDF]
Sci RepGu JX +10 more
europepmc +1 more source
Atorvastatin enhances LDL receptor-mediated LDL-C uptake and modulates PCSK9 protein expression in pancreatic β-cells. [PDF]
IsletsZhang Z +9 more
europepmc +1 more source
CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism [PDF]
, 2014 Bin Dong +4 more
openalex +1 more source
Liječenje hiperlipidemija PCSK9 inhibitorima
, 2022 Kardiovaskularne i cerebrovaskularne bolesti vodeći su uzrok smrti u Hrvatskoj i svijetu. Jedan od najvažnijih faktora rizika za razvoj kardiovaskularnih bolesti je hiperlipidemija. Iz tog razloga liječenje hiperlipidemija i održavanje ciljnih vrijednosti kolesterola ističu se kao jedan od najvažnijih ciljeva u prevenciji i liječenju kardiovaskularnih ...
openaire +2 more sources
Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans [PDF]
, 2014 Ylva Bonde +5 more
openalex +1 more source
PCSK9 Enhances Cardiac Fibrogenesis via the Activation of Toll-like Receptor and NLRP3 Inflammasome Signaling. [PDF]
Int J Mol SciChung CC +6 more
europepmc +1 more source
HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment? [PDF]
, 2016 Morozzi, Claudia, Stefanutti, Claudia
core +1 more source